Molecular Partners（纳斯达克股票代码：MOLN）报告本季度每股亏损为$(1.81)。与去年同期每股亏损$(2.13)相比，减少了15.1%。公司本季度报告的销售额为$5.65百万。与去年同期的销售额$7.89百万相比，减少了28.46%。

以上内容来自Benzinga Earnings专栏，原文如下：

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(1.81) per share. This is a 15.1 percent increase over losses of $(2.13) per share from the same period last year. The company reported $5.65 million in sales this quarter. This is a 28.46 percent decrease over sales of $7.89 million the same period last year.